Why the study?
Does carvedilol reduce mortality and hospitalization in patients with congestive heart failure?
Population
Patients with congestive heart failure (CHF)
Comparison
Carvedilol vs Placebo
Design
Review
Loading...
May support carvedilol in CHF to cut mortality and hospitalization; leaves open need for prospective validation in broader populations.
Does carvedilol reduce mortality and hospitalization in patients with congestive heart failure?
Carvedilol, a multiple-action neurohormonal antagonist and antioxidant, reduces mortality and hospitalization in CHF, potentially by inhibiting apoptosis and protecting against oxygen free radicals.
A 1998 study studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: